Rates of asthma attacks in patients with previously inadequately controlled mild asthma treated in clinical practice with combination drug therapy: An exploratory post-hoc analysis

BMC Pulmonary Medicine

Volumn 9, Issue , 2009, Pages

  Dal Negro, Robert W ^a   Borderias, Luis ^b   Zhang, Qiaoyi ^c   Fan, Tao ^c   Sazonov, Vasilisa ^c   Guilera, Magda ^d   Taylor, Stephanie D ^c  

^a Bussolengo Gen Hospital   (Italy)

^b HOSPITAL SAN JORGE   (Spain)

^c MERCK RESEARCH LABORATORIES   (United States)

^d HOR Europe   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID DERIVATIVE; LONG ACTING DRUG; MONTELUKAST; SHORT ACTING DRUG; ACETIC ACID DERIVATIVE; ANTIASTHMATIC AGENT; GLUCOCORTICOID; QUINOLINE DERIVATIVE;

ADULT; ALLERGIC RHINITIS; ARTICLE; CLINICAL PRACTICE; COHORT ANALYSIS; CONTROLLED STUDY; EXPLORATORY RESEARCH; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD PERSISTENT ASTHMA; MONOTHERAPY; OBSERVATIONAL STUDY; POST HOC ANALYSIS; PRESCRIPTION; PRETEST POSTTEST DESIGN; RETROSPECTIVE STUDY; ADOLESCENT; ASTHMA; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG COMBINATION; EUROPE; FOLLOW UP; INCIDENCE; INHALATIONAL DRUG ADMINISTRATION; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; RECURRENT DISEASE; TIME;

ACETATES; ADMINISTRATION, INHALATION; ADOLESCENT; ADRENERGIC BETA-AGONISTS; ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA; DRUG THERAPY, COMBINATION; EUROPE; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; QUINOLINES; RECURRENCE; RETROSPECTIVE STUDIES; TIME FACTORS; YOUNG ADULT;

EID: 65549170361     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-9-10     Document Type: Article

References (22)

1. Bousquet J Van Cauwenberge P Khaltaev N Allergic rhinitis and its impact onasthma J Allergy Clin Immunol 2001, 108:S147-334. 10.1067/ mai.2001.118891 11707753
2. Global Initiative for Asthma Global strategy for asthma management and prevention, 2006
3. Guidelines for the Diagnosis and Management of Asthma. Expert Panel Report 3 Full Report: National Heart, Lung, and Blood Institute National Asthma Education and Prevention Program 2007
4. Chervinsky P Philip G Malice MP Bardelas J Nayak A Marchal JL van Adelsberg J Bousquet J Tozzi CA Reiss TF Montelukast for treating fall allergic rhinitis: Effect of pollen exposure in 3 studies Ann Allergy Asthma Immunol 2004, 92:367-73. 15049402
5. Philip G Nayak AS Berger WE Leynadier F Vrijens F Dass SB Reiss TF The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis Current medical research and opinion 2004, 20:1549-58. 10.1185/030079904X3348
6. Martinez FD Safety of long-acting beta-agonists - an urgent need to clear the air The New England journal of medicine 2005, 353:2637-9. 10.1056/NEJMp058299 16371628
7. Glassroth J The role of long-acting beta-agonists in the management of asthma: Analysis, meta-analysis, and more analysis Annals of internal medicine 2006, 144:936-7. 16754915
8. Walters EH Gibson PG Lasserson TJ Walters JA Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid Cochrane Database Syst Rev 2007:CD001385. 17253458
9. Hasford J Virchow JC Excess mortality in patients with asthma on long-acting beta2-agonists Eur Respir J 2006, 28:900-2. 10.1183/ 09031936.00085606 17074917
10. Bhagat R Kalra S Swystun VA Cockcroft DW Rapid onset of tolerance to the bronchoprotective effect of salmeterol Chest 1995, 108:1235-9. 10.1378/ chest.108.5.1235 7587422
11. Lipworth BJ Aziz I A high dose of albuterol does not overcome bronchoprotective subsensitivity in asthmatic subjects receiving regular salmeterol or formoterol J Allergy Clin Immunol 1999, 103:88-92. 10.1016/ S0091-6749(99)70530-0 9893190
12. Aziz I Lipworth BJ In vivo effect of albuterol on methacholine-contracted bronchi in conjunction with salmeterol and formoterol J Allergy Clin Immunol 1999, 103:816-22. 10.1016/ S0091-6749(99)70425-2 10329815
13. Woude van der HJ Winter TH Aalbers R Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists Thorax 2001, 56:529-35. 1746085 11413351 10.1136/thorax.56.7.529
14. Lipworth BJ Long-acting beta(2)-adrenoceptor agonists: A smart choice for asthma? Trends Pharmacol Sci 2007, 28:257-62. 10.1016/ j.tips.2007.04.003 17466387
15. Ernst P McIvor A Ducharme FM Boulet LP FitzGerald M Chapman KR Bai T Canadian Asthma Guideline Group Safety and effectiveness of long-acting inhaled beta-agonist bronchodilators when taken with inhaled corticosteroids Annals of internal medicine 2006, 145:692-4. 17088583
16. Borderias L Mincewicz G Paggiaro PL Guilera M Sazonov Kocevar V Taylor SD Badia X Asthma control in patients with asthma and allergic rhinitis receiving add-on montelukast therapy for 12 months: A retrospective observational study Current medical research and opinion 2007, 23:721-30. 10.1185/030079906X167606
17. Ducharme F Schwartz Z Hicks G Kakuma R Addition of anti-leukotriene agents to inhaled corticosteroids for chronic asthma Cochrane Database Syst Rev 2004:CD003133. 15106191
18. Gibson PG Powell H Ducharme FM Differential effects of maintenance long-acting beta-agonist and inhaled corticosteroid on asthma control and asthma exacerbations J Allergy Clin Immunol 2007, 119:344-50. 10.1016/j.jaci.2006.10.043 17291852
19. Robinson DS Campbell D Barnes PJ Addition of leukotriene antagonists to therapy in chronic persistent asthma: A randomised double-blind placebo-controlled trial Lancet 2001, 357:2007-11. 10.1016/ S0140-6736(00)05113-8 11438132
20. Nathan RA Yancey SW Waitkus-Edwards K Prillaman BA Stauffer JL Philpot E Dorinsky PM Nelson HS Fluticasone propionate nasal spray is superior to montelukast for allergic rhinitis while neither affects overall asthma control Chest 2005, 128:1910-20. 10.1378/chest.128.4.1910 16236835
21. Currie GP Lee DK Dempsey OJ Fowler SJ Cowan LM Lipworth BJ A proof of concept study to evaluate putative benefits of montelukast in moderate persistent asthmatics Br J Clin Pharmacol 2003, 55:609-15. 1884256 12814457 10.1046/j.1365-2125.2003.01813.x
22. Currie GP Lee DK Haggart K Bates CE Lipworth BJ Effects of montelukast on surrogate inflammatory markers in corticosteroid-treated patients with asthma Am J Respir Crit Care Med 2003, 167:1232-8. 10.1164/ rccm.200209-1116OC 12456382